Search research articles
Contact Us
Filters
Showing results (321-330 of 377) with videos related to
Page
of 38
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 21, 2021
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion
Fabio Conforti, Laura Pala, Eleonora Pagan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 20, 2019
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial
Enrica Capelletto, Maria Rita Migliorino, Alessandro Morabito, et al.
American Journal of Cancer Research
|
September 2, 2015
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification
Matteo Brunelli, Alessia Nottegar, Giuseppe Bogina, et al.
JAMA Oncology
|
September 8, 2018
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
Roberto Ferrara, Laura Mezquita, Matthieu Texier, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 5, 2016
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study
Tiziana Vavalà, Alessandro Follador, Marcello Tiseo, et al.
NPJ Breast Cancer
|
February 5, 2025
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy
Luca Mastrantoni, Giovanna Garufi, Giulia Giordano, et al.
JCO Precision Oncology
|
June 12, 2026
Liquid Biopsy Monitoring in <i>BRAF</i> V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020)
Alessandro Leonetti, Monica Pluchino, Roberta Minari, et al.
Frontiers in Oncology
|
July 24, 2024
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study
Marco Sposito, Lorenzo Belluomini, Riccardo Nocini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2022
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences
Fabrizio Tabbò, Lucia Anna Muscarella, Elisa Gobbini, et al.
Cancer Discovery
|
July 12, 2020
Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated Macrophages
Ilaria Marigo, Rosalinda Trovato, Francesca Hofer, et al.
Page
of 38
Search research articles
Search
Showing results (321-330 of 377) with videos related to
Sort By:
Page
of 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 21, 2021
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion
Fabio Conforti, Laura Pala, Eleonora Pagan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 20, 2019
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial
Enrica Capelletto, Maria Rita Migliorino, Alessandro Morabito, et al.
American Journal of Cancer Research
|
September 2, 2015
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification
Matteo Brunelli, Alessia Nottegar, Giuseppe Bogina, et al.
JAMA Oncology
|
September 8, 2018
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
Roberto Ferrara, Laura Mezquita, Matthieu Texier, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 5, 2016
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study
Tiziana Vavalà, Alessandro Follador, Marcello Tiseo, et al.
NPJ Breast Cancer
|
February 5, 2025
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy
Luca Mastrantoni, Giovanna Garufi, Giulia Giordano, et al.
JCO Precision Oncology
|
June 12, 2026
Liquid Biopsy Monitoring in <i>BRAF</i> V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020)
Alessandro Leonetti, Monica Pluchino, Roberta Minari, et al.
Frontiers in Oncology
|
July 24, 2024
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study
Marco Sposito, Lorenzo Belluomini, Riccardo Nocini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2022
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences
Fabrizio Tabbò, Lucia Anna Muscarella, Elisa Gobbini, et al.
Cancer Discovery
|
July 12, 2020
Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated Macrophages
Ilaria Marigo, Rosalinda Trovato, Francesca Hofer, et al.
Page
of 38